SCHEMBL31148136

SCHEMBL31148136

O=C(Nc1ccc(C2CC2)cc1)[C@H]1CCCN(CCc2ccccn2)C1

nearest known ligand 0.58

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
DRD3 P35462 1/20 0.55
SMN1; SMN2 Q16637 2/20 0.50
USP2 O75604 1/20 0.50
ALOX15 P16050 1/20 0.50
HSD17B10 Q99714 1/20 0.50
TSHR P16473 2/20 0.47
RHOA P61586 2/20 0.46
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
ALDH1A1 P00352 2/20 0.45
OGA O60502 1/20 0.45
LMNA P02545 1/20 0.45
POLB P06746 1/20 0.45
HPGD P15428 1/20 0.45
KDM4E B2RXH2 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31148132 1.00 DRD3 (0.55) DRD3SMN1; SMN2USP2ALOX15HSD17B10
SCHEMBL31148242 0.82 HRH3 (0.51) SMN1; SMN2USP2ALOX15HSD17B10ALDH1A1
SCHEMBL8097066 0.80 SLC6A1 (0.57) HSD17B10TSHRALDH1A1LMNA
SCHEMBL31148163 0.79 USP2 (0.48) SMN1; SMN2USP2ALOX15HSD17B10LMNA
SCHEMBL31148239 0.78 ADRB2 (0.50) SMN1; SMN2USP2ALOX15HSD17B10TSHR
SCHEMBL5870879 0.75 DRD3 (0.77) DRD3RAB9AOGAPOLBHPGD
SCHEMBL8103609 0.74 ALDH1A1 (0.62) SMN1; SMN2ALDH1A1KDM4E
SCHEMBL5714253 0.74 TP53 (0.48) DRD3TSHRRHOALMNA
SCHEMBL5841484 0.72 L3MBTL1 (0.54) SMN1; SMN2POLBKDM4E
SCHEMBL31148024 0.71 ALDH1A1 (0.48) SMN1; SMN2USP2ALOX15HSD17B10NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4695236-A1 SUBSTITUTED PHENYL-PIPERAZINYL BASED MODULATORS FOR THE TREATMENT OF DISEASE Soley Therapeutics, Inc. (US) 2026-02-18 EP disclosed
WO-2024216094-A1 SUBSTITUTED PHENYL-PIPERAZINYL BASED MODULATORS FOR THE TREATMENT OF DISEASE SOLEY THERAPEUTICS, INC. (US) 2024-10-17 WO disclosed